/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZKS7OXUCFZOGZI3ROI3QUVLBQU.jpg?resize=400%2C240&ssl=1 "GSK lifts growth target for HIV business on demand for long-acting drug")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZKS7OXUCFZOGZI3ROI3QUVLBQU.jpg?resize=80%2C80&ssl=1 "GSK lifts growth target for HIV business on demand for long-acting drug")
GSK (GlaxoSmithKline) logo is seen in this illustration, August 10, 2022. REUTERS/Dado Ruvic/Illustration/File photo Acquire Licensing Rights Sept 28 – GSK (GSK.L) on Thursday lifted its...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IXYUV47KYRP5DGR3BXFFW4NLJE.jpg?resize=400%2C240&ssl=1 "US FDA declines to approve first nasal spray equivalent of EpiPen")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/IXYUV47KYRP5DGR3BXFFW4NLJE.jpg?resize=80%2C80&ssl=1 "US FDA declines to approve first nasal spray equivalent of EpiPen")
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights...
Sept 15 (Reuters) – The U.S. National Institutes of Health (NIH) said on Friday that it has begun an early-stage study on its vaccine targeting...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/KQY6Q2HQGROSVPRNTFTB2D3LJU.jpg?resize=400%2C240&ssl=1 "Novavax’s updated COVID shot shows immune response against subvariant Eris")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/KQY6Q2HQGROSVPRNTFTB2D3LJU.jpg?resize=80%2C80&ssl=1 "Novavax’s updated COVID shot shows immune response against subvariant Eris")
A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights Aug 22 (Reuters) –...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7I5ISTG4WJMYTANJJELKH63UDQ.jpg?resize=400%2C240&ssl=1 "Biden administration to urge Americans get new COVID-19 boosters")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/7I5ISTG4WJMYTANJJELKH63UDQ.jpg?resize=80%2C80&ssl=1 "Biden administration to urge Americans get new COVID-19 boosters")
A 50-year-old and immunocompromised resident receives a second booster shot of the coronavirus disease (COVID-19) vaccine in Waterford, Michigan, U.S., April 8, 2022. REUTERS/Emily Elconin/File Photo...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZVHZKD4JKRJOBLJTOPWJXKQKTY.jpg?resize=400%2C240&ssl=1 "Eris, BA.2.86: Do I need to worry about COVID again?")
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ZVHZKD4JKRJOBLJTOPWJXKQKTY.jpg?resize=80%2C80&ssl=1 "Eris, BA.2.86: Do I need to worry about COVID again?")
[1/3]A nurse fills up syringes with the coronavirus disease (COVID-19) vaccines for residents who are over 50 years old and immunocompromised and are eligible to receive...
Recent Comments